Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 235265, 9 pages
http://dx.doi.org/10.1155/2015/235265
Research Article

Icariin Prevents Amyloid Beta-Induced Apoptosis via the PI3K/Akt Pathway in PC-12 Cells

1Department of Integrated Chinese and Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
2Department of Traditional Chinese Medicine, Zhong Shan Hospital Xiamen University, Xiamen, Fujian 361004, China

Received 25 November 2014; Accepted 5 January 2015

Academic Editor: Ki-Wan Oh

Copyright © 2015 Dongdong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Reitz, C. Brayne, and R. Mayeux, “Epidemiology of Alzheimer disease,” Nature Reviews Neurology, vol. 7, no. 3, pp. 137–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Huang and L. Mucke, “Alzheimer mechanisms and therapeutic strategies,” Cell, vol. 148, no. 6, pp. 1204–1222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Ballard, S. Gauthier, A. Corbett, C. Brayne, D. Aarsland, and E. Jones, “Alzheimer's disease,” The Lancet, vol. 377, no. 9770, pp. 1019–1031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Karran, M. Mercken, and B. D. Strooper, “The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics,” Nature Reviews Drug Discovery, vol. 10, no. 9, pp. 698–712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Serrano-Pozo, M. P. Frosch, E. Masliah, and B. T. Hyman, “Neuropathological alterations in Alzheimer disease,” Cold Spring Harbor Perspectives in Medicine, vol. 1, no. 1, Article ID a006189, 2011. View at Publisher · View at Google Scholar
  7. C. Behl, “Apoptosis and Alzheimer's disease,” Journal of Neural Transmission, vol. 107, no. 11, pp. 1325–1344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ankarcrona and B. Winblad, “Biomarkers for apoptosis in Alzheimer's disease,” International Journal of Geriatric Psychiatry, vol. 20, no. 2, pp. 101–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Calissano, C. Matrone, and G. Amadoro, “Apoptosis and in vitro Alzheimer disease neuronal models,” Communicative and Integrative Biology, vol. 2, no. 2, pp. 163–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Camins, M. Pallàs, and J. S. Silvestre, “Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 30, no. 1, pp. 43–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Vila and S. Przedborski, “Targeting programmed cell death in neurodegenerative diseases,” Nature Reviews Neuroscience, vol. 4, no. 5, pp. 365–375, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Song, G. Ouyang, and S. Bao, “The activation of Akt/PKB signaling pathway and cell survival,” Journal of Cellular and Molecular Medicine, vol. 9, no. 1, pp. 59–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Yuan and B. A. Yankner, “Apoptosis in the nervous system,” Nature, vol. 407, no. 6805, pp. 802–809, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Wing Sze, Y. Tong, T. B. Ng, C. L. Yin Cheng, and H. P. Cheung, “Herba Epimedii: anti-oxidative properties and its medical implications,” Molecules, vol. 15, no. 11, pp. 7861–7870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Guo, F. Li, Q. Wu, Q. Gong, Y. Lu, and J. Shi, “Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats,” Phytomedicine, vol. 17, no. 12, pp. 950–955, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Li, P. Dong, J. Wang et al., “Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway,” Cancer Letters, vol. 298, no. 2, pp. 222–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhou, J. Wu, X. Chen et al., “Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions,” International Immunopharmacology, vol. 11, no. 7, pp. 890–898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Wang, X. Zhang, H. Wang, L. Qi, and Y. Lou, “Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway,” Neuroscience, vol. 145, no. 3, pp. 911–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Yang, D. Lu, J. Guo, X. Meng, G. Zhang, and F. Wang, “Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by aromatase (CYP19),” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 715–721, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Nie, Y. Luo, X.-N. Huang, Q.-H. Gong, Q. Wu, and J.-S. Shi, “Icariin inhibits beta-amyloid peptide segment 25–35 induced expression of beta-secretase in rat hippocampus,” European Journal of Pharmacology, vol. 626, no. 2-3, pp. 213–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Urano and C. Tohda, “Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β-induced neurite atrophy,” Phytotherapy Research, vol. 24, no. 11, pp. 1658–1663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X.-L. He, W.-Q. Zhou, M.-G. Bi, and G.-H. Du, “Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescence-accelerated mouse prone 8 (SAMP8) mice,” Brain Research, vol. 1334, pp. 73–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K.-W. Zeng, H. Ko, H. O. Yang, and X.-M. Wang, “Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells,” Neuropharmacology, vol. 59, no. 6, pp. 542–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Zhang, B. Liu, J. Wu et al., “Icariin inhibits corticosterone-induced apoptosis in hypothalamic neurons via the PI3-K/Akt signaling pathway,” Molecular Medicine Reports, vol. 6, no. 5, pp. 967–972, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-H. Lee, Y.-H. Cheon, R.-S. Woo, D.-Y. Song, C. Moon, and T.-K. Baik, “Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain,” Anatomy & Cell Biology, vol. 45, no. 1, pp. 26–37, 2012. View at Publisher · View at Google Scholar
  26. W. Yu, N. Mechawar, S. Krantic, and R. Quirion, “Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease,” The American Journal of Pathology, vol. 176, no. 5, pp. 2209–2218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Eckert, C. A. Marques, U. Keil, K. Schüssel, and W. E. Müller, “Increased apoptotic cell death in sporadic and genetic Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 1010, pp. 604–609, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Smale, N. R. Nichols, D. R. Brady, C. E. Finch, and W. E. Horton Jr., “Evidence for apoptotic cell death in Alzheimer's disease,” Experimental Neurology, vol. 133, no. 2, pp. 225–230, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Donev, M. Kolev, B. Millet, and J. Thome, “Neuronal death in Alzheimer's disease and therapeutic opportunities,” Journal of Cellular and Molecular Medicine, vol. 13, no. 11-12, pp. 4329–4348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Duronio, “The life of a cell: apoptosis regulation by the PI3K/PKB pathway,” Biochemical Journal, vol. 415, no. 3, pp. 333–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. A. Hemmings, “Akt signaling: linking membrane events to life and death decisions,” Science, vol. 275, no. 5300, pp. 628–630, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-K. Lee, P. Kumar, Q. Fu, K. M. Rosen, and H. W. Querfurth, “The insulin/Akt signaling pathway is targeted by intracellular β-amyloid,” Molecular Biology of the Cell, vol. 20, no. 5, pp. 1533–1544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Rickle, N. Bogdanovic, I. Volkman, B. Winblad, R. Ravid, and R. F. Cowburn, “Akt activity in Alzheimer's disease and other neurodegenerative disorders,” NeuroReport, vol. 15, no. 6, pp. 955–959, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-Q. Xu, B.-J. Liu, J.-F. Wu et al., “Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NFκB signaling pathway,” European Journal of Pharmacology, vol. 642, no. 1–3, pp. 146–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. W.-J. Cai, J.-H. Huang, S.-Q. Zhang et al., “Icariin and its derivative icariside II extend healthspan via insulin/IGF-1 pathway in C. elegans,” PLoS ONE, vol. 6, no. 12, Article ID e28835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Vanhaesebroeck, L. Stephens, and P. Hawkins, “PI3K signalling: the path to discovery and understanding,” Nature Reviews Molecular Cell Biology, vol. 13, no. 3, pp. 195–203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Adams and S. Cory, “The Bcl-2 protein family: arbiters of cell survival,” Science, vol. 281, no. 5381, pp. 1322–1326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Snigdha, E. D. Smith, G. A. Prieto, and C. W. Cotman, “Caspase-3 activation as a bifurcation point between plasticity and cell death,” Neuroscience Bulletin, vol. 28, no. 1, pp. 14–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. D'Amelio, M. Sheng, and F. Cecconi, “Caspase-3 in the central nervous system: beyond apoptosis,” Trends in Neurosciences, vol. 35, no. 11, pp. 700–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Cagnol and J. C. Chambard, “ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence,” FEBS Journal, vol. 277, no. 1, pp. 2–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Nan, X. Zhang, G. Yang et al., “Icariin stimulates the proliferation of rat Sertoli cells in an ERK1/2-dependent manner in vitro,” Andrologia, vol. 46, no. 1, pp. 9–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. B. H. Chung, J. D. Kim, C. K. Kim et al., “Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells,” Biochemical and Biophysical Research Communications, vol. 376, no. 2, pp. 404–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Liu, H. Zhang, C. Xu et al., “Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons,” Brain Research, vol. 1375, pp. 59–67, 2011. View at Publisher · View at Google Scholar · View at Scopus